{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:53:36Z","timestamp":1785365616166,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.amepre.2018.01.034","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T20:03:59Z","timestamp":1521403439000},"page":"652-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Trends in Medical Use of Opioids in the U.S., 2006\u20132016"],"prefix":"10.1016","volume":"54","author":[{"given":"Brian J.","family":"Piper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipam T.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olapeju M.","family":"Simoyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.amepre.2018.01.034_bib1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Med Care"},{"issue":"1\u20132","key":"10.1016\/j.amepre.2018.01.034_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drugalcdep.2013.01.006","article-title":"Relationship of opioid prescription sales and overdoses, North Carolina","volume":"132","author":"Modari","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"5051","key":"10.1016\/j.amepre.2018.01.034_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increase in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"26","key":"10.1016\/j.amepre.2018.01.034_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2018.01.034_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2017.03.011","article-title":"Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004\u20132013","volume":"176","author":"Jones","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.amepre.2018.01.034_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amepre.2018.01.034_bib7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2018.01.034_bib8","series-title":"Monitoring the Future: National Survey Results on Drug Use: 1975-2016. Secondary School Students","author":"Miech","year":"2016"},{"key":"10.1016\/j.amepre.2018.01.034_bib9","unstructured":"Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. HHS Publication No. SMA 16-4984, NSDUH Series H-51. www.samhsa.gov\/data\/. Published 2016."},{"issue":"6","key":"10.1016\/j.amepre.2018.01.034_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/14659891.2012.685794","article-title":"Controlled substance prescribing trends and physician and pharmacy utilization patterns: epidemiological analysis of the Maine Prescription Monitoring Program from 2006 to 2010","volume":"18","author":"McCall","year":"2013","journal-title":"J Substance Use"},{"issue":"4","key":"10.1016\/j.amepre.2018.01.034_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.15288\/jsad.2016.77.556","article-title":"Use and misuse of opioids in Maine: results from pharmacists, the Prescription Monitoring, and the Diversion Alert Programs","volume":"77","author":"Piper","year":"2016","journal-title":"J Stud Alcohol Drugs"},{"issue":"2","key":"10.1016\/j.amepre.2018.01.034_bib12","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.36076\/ppj.2014\/17\/E119","article-title":"Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011","volume":"17","author":"Atluri","year":"2014","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.amepre.2018.01.034_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/003335491412900207","article-title":"Prescription drug monitoring and dispensing of prescription opioids","volume":"129","author":"Brady","year":"2014","journal-title":"Public Health Rep"},{"issue":"2","key":"10.1016\/j.amepre.2018.01.034_bib14","first-page":"e41","article-title":"Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000\u20132010","volume":"6","author":"Kenan","year":"2012","journal-title":"Open Med"},{"key":"10.1016\/j.amepre.2018.01.034_bib15","first-page":"41","article-title":"Prescription opioid usage and abuse relationships: An evaluation of state Prescription Drug Monitoring program efficacy","volume":"3","author":"Reisman","year":"2009","journal-title":"Subst Abuse"},{"key":"10.1016\/j.amepre.2018.01.034_bib16","article-title":"Physician dispensing of oxycodone and other commonly used opioids, 2000\u20132015, United States","author":"Mack","year":"2017","journal-title":"Pain Med. In press. Online"},{"issue":"3","key":"10.1016\/j.amepre.2018.01.034_bib17","first-page":"165","article-title":"Trends in the distribution of opioids in Puerto Rico, 1999\u20132013","volume":"35","author":"F\u00e9lix","year":"2016","journal-title":"P R Health Science J"},{"issue":"6","key":"10.1016\/j.amepre.2018.01.034_bib18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amepre.2006.08.017","article-title":"Opioid analgesics and rates of fatal drug poisoning in the United States","volume":"31","author":"Paulozzi","year":"2006","journal-title":"Am J Prev Med"},{"issue":"6","key":"10.1016\/j.amepre.2018.01.034_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for non-cancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.amepre.2018.01.034_bib20","unstructured":"Centers for Disease Control and Prevention (CDC). Calculating total daily dose of opioids for safer dosage. www.cdc.gov\/drugoverdose\/pdf\/calculating_total_daily_dose-a.pdf. Accessed November 1, 2017."},{"issue":"43","key":"10.1016\/j.amepre.2018.01.034_bib21","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999\u20132008","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.amepre.2018.01.034_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.amepre.2018.01.034_bib23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amepre.2018.01.034_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2105\/AJPH.2015.302953","article-title":"Opioid overdose deaths and Florida\u2019s crackdown on pill mills","volume":"106","author":"Kennedy-Hendricks","year":"2016","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.amepre.2018.01.034_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/pds.3553","article-title":"Reductions in prescription opioid diversion following recent legislative interventions in Florida","volume":"23","author":"Surratt","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.amepre.2018.01.034_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of OxyContin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.amepre.2018.01.034_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"issue":"15","key":"10.1016\/j.amepre.2018.01.034_bib28","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.amepre.2018.01.034_bib29","first-page":"2227","article-title":"2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"63","author":"American Geriatrics Society","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.amepre.2018.01.034_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000433-199203000-00009","article-title":"Lethal effects of normeperidine","volume":"13","author":"Jiraki","year":"1992","journal-title":"Am J Forensic Med Pathol"},{"issue":"3","key":"10.1016\/j.amepre.2018.01.034_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamainternmed.2015.7799","article-title":"Effect of U.S. Drug Enforcement Administration\u2019s rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing","volume":"176","author":"Jones","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2018.01.034_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08897077.2015.1080208","article-title":"Policies related to opioid agonist therapy for opioid use disorders: the evolution of state policies from 2004 to 2013","volume":"37","author":"Burns","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.amepre.2018.01.034_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Current Psychiatry Rep"},{"key":"10.1016\/j.amepre.2018.01.034_bib34","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amepre.2018.01.034_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000199046","article-title":"A literature review of international implementation of opioid substitution treatment in prisons: Equivalence of care?","volume":"15","author":"Larney","year":"2009","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.amepre.2018.01.034_bib36","first-page":"CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","volume":"3","author":"Faggiano","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amepre.2018.01.034_bib37","first-page":"CD012499","article-title":"Methadone for neuropathic pain in adults","volume":"5","author":"McNicol","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amepre.2018.01.034_bib38","first-page":"CD008025","article-title":"Methadone for chronic non-cancer pain in adults","volume":"11","author":"Harroutonian","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amepre.2018.01.034_bib39","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","volume":"5","author":"Nielsen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.amepre.2018.01.034_bib40","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010\u20132014","volume":"65","author":"Warner","year":"2016","journal-title":"Natl Vital Stat Rep"},{"issue":"7","key":"10.1016\/j.amepre.2018.01.034_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/phar.1952","article-title":"A new tool to tackle the opioid epidemic: description, utility, and results from the Maine Diversion Alert Program","volume":"37","author":"Piper","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"16","key":"10.1016\/j.amepre.2018.01.034_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6616a1","article-title":"Surveillance for certain health behaviors and conditions among states and selected local areas\u2014Behavioral Risk Factor Surveillance System, United States","volume":"66","author":"Gamble","year":"2017","journal-title":"2013 and 2014. MMWR Surveill Summ"},{"issue":"2","key":"10.1016\/j.amepre.2018.01.034_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1353\/hpu.2017.0049","article-title":"Prevention programming in the U.S. Virgin Islands","volume":"28","author":"Battiste","year":"2017","journal-title":"J Health Care Poor Underserved"},{"key":"10.1016\/j.amepre.2018.01.034_bib44","unstructured":"World Bank. Life expectancy at birth. https:\/\/data.worldbank.org\/indicator\/SP.DYN.LE00.IN. Accessed November 12, 2017."},{"issue":"11","key":"10.1016\/j.amepre.2018.01.034_bib45","first-page":"1065","article-title":"Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000\u20132015","volume":"318","author":"Dowell","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2018.01.034_bib46","unstructured":"Kochanek KD, Arias E, Bastian BA. The effect of changes in selected age-specific causes of death on non-Hispanic white life expectancy between 2000 and 2014. National Center for Health Statistics Data Brief 2016; #250. www.cdc.gov\/nchs\/data\/databriefs\/db250.pdf. Accessed November 10, 2017."},{"issue":"6","key":"10.1016\/j.amepre.2018.01.034_bib47","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jemermed.2015.06.035","article-title":"Emergency visits for prescription opioid poisonings","volume":"49","author":"Tadros","year":"2015","journal-title":"J Emerg Med"},{"issue":"16","key":"10.1016\/j.amepre.2018.01.034_bib48","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.2017.14567","article-title":"Ten steps the federal government should take now to reverse the opioid addiction epidemic","volume":"318","author":"Kolodny","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2018.01.034_bib49","unstructured":"Christie C, Baker C, Cooper R, et al. The President\u2019s commission on combating drug addiction and the opioid crisis. https:\/\/assets.documentcloud.org\/documents\/4165486\/Final-report-from-the-president-s-opioid.pdf. Accessed November 5, 2017."},{"issue":"5","key":"10.1016\/j.amepre.2018.01.034_bib50","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1213\/ANE.0000000000002403","article-title":"The U.S. opioid crisis: current federal and state legal issues","volume":"125","author":"Soelberg","year":"2017","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.amepre.2018.01.034_bib51","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.drugpo.2014.07.009","article-title":"Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons","volume":"25","author":"Weisberg","year":"2014","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2018.01.034_bib52","unstructured":"Lawlor J. CMS drops pain questions from satisfaction surveys. www.ihexecutive.com\/regulatory-compliance\/cms\/article\/20840769\/cms-drops-pain-questions-from-satisfaction-surveys. Accessed November 8, 2017."},{"key":"10.1016\/j.amepre.2018.01.034_bib53","series-title":"Data on Substance Abuse Treatment Facilities. BHSIS Series S-93, HHS Publication No. (SMA) 17-5039","year":"2017"},{"key":"10.1016\/j.amepre.2018.01.034_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment\u2014a nation-wide register-based open cohort study","volume":"174","author":"Abrahammson","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.amepre.2018.01.034_bib55","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamainternmed.2016.8471","article-title":"Financial conflicts of interest and the Centers for Disease Control and Prevention\u2019s 2016 guideline for prescribing opioids for chronic pain","volume":"177","author":"Lin","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amepre.2018.01.034_bib56","unstructured":"Higman S, Bernstein L. The drug industry\u2019s triumph over the DEA. Washington Post. www.washingtonpost.com\/graphics\/2017\/investigations\/dea-drug-industry-congress\/?hpid=hp_hp-top-table-low_deanarrative-hed%3Ahomepage%2Fstory&utm_term=.4d3d582cd92e. Published October 15, 2017. Accessed November 5, 2017."},{"issue":"1","key":"10.1016\/j.amepre.2018.01.034_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/tcrm.2007.3.1.41","article-title":"Drug reimportation practices in the United States","volume":"3","author":"Bhosle","year":"2007","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"10.1016\/j.amepre.2018.01.034_bib58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/01947640601021105","article-title":"United States prescription drug crisis: Reimportation of Canadian prescription drugs is not the answer","volume":"27","author":"Martin","year":"2006","journal-title":"J Leg Med"},{"key":"10.1016\/j.amepre.2018.01.034_bib59","series-title":"Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics","article-title":"Opioids, analgesia, and pain management","author":"Yaksh","year":"2018"},{"issue":"5","key":"10.1016\/j.amepre.2018.01.034_bib60","first-page":"892","article-title":"Variability in opioid equivalence calculations","volume":"17","author":"Rennick","year":"2016","journal-title":"Pain Med"},{"issue":"7\u20138","key":"10.1016\/j.amepre.2018.01.034_bib61","first-page":"435","article-title":"Pharmacology of methadone and its isomers","volume":"71","author":"Inturrisi","year":"2005","journal-title":"Minerva Anestesiol"},{"issue":"4","key":"10.1016\/j.amepre.2018.01.034_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.amepre.2018.01.034_bib63","unstructured":"Bartholow M. Top 200 drugs of 2011. Pharmacy Times. www.pharmacytimes.com\/publications\/issue\/2012\/july2012\/top-200-drugs-of-2011. Published July 10, 2012. Accessed December 26, 2017."}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379718300667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379718300667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T09:21:36Z","timestamp":1660641696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379718300667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0749379718300667"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2018.01.034","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Medical Use of Opioids in the U.S., 2006\u20132016","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2018.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}